The Essentials of Tobacco and Nicotine Product Research
Recorded July 14, 2021 | On-Demand Webinar
Part of the Summer Learning Series
Author Happy Hour: Evolving Food and Dietary Supplement Class Action Suits
June 30, 2021 | 5:00 PM EDT | Virtual Event
The Essentials of Statistics for Medical Products Lawyers
Recorded June 30, 2021 | On-Demand Webinar
Part of the Summer Learning Series
Food and Dietary Supplement Class Action Litigation: Roundtable Discussion on Recent Filings and Current Trends
Recorded June 17, 2021 | On-Demand Webinar
The Essentials of Clinical Trial Science
Recorded June 16, 2021 | On-Demand Webinar
Part of the Summer Learning Series
Regenerative Medicine: Regulatory, Legal, and Compliance Challenges for Cell and Gene Therapies
June 8–9, 2021 | Virtual Event
FDA Drug Manufacturing Oversight During Covid-19: The GAO Report on the Inspections Backlog and Steps FDA is Taking to Address It
Update Magazine | Summer 2021
How Does FDA’s Recent Guidance on Remote Interactive Evaluations Change the Inspections Landscape?
Recorded May 26, 2021 | On-Demand Webinar
Orphan Drugs in Canada: A “One Size Fits All” Regulatory Regime
Orphan Drugs in Canada: A “One Size Fits All” Regulatory Regime By Eileen McMahon and Denise Ramsden Introduction Medicines targeting rare diseases, also known as orphan drugs,[1] once faced an uphill battle for research funding and market approval. The need for robust commercial incentives to create rare disease treatments spurred the establishment [...]
Food and Supplement Class Action Suits That Rely on Alleged Regulatory Violations
Update Magazine | Summer 2021
